en
Novel coamoxiclav formulations are described, having reduced weight compared to existing formulations, as well as formulations comprising amoxycillin and potassium clavulanate in a ratio of 8:1 and formulations prepared from granulates of amoxycillin and granulates of amoxycillin and clavulanate.
Datos clave
CategoríaInvención
Índice de la ficha
- Updated at
- 05/11/2026
- Numero publicacion
- US.2003124187.A1
- Fecha publicacion
- 03/07/2003
- Anio publicacion
- 2003
- Numero solicitud
- US20020302199
Etiquetas
Inventores
Mention Jacky Andre GustaveSanroma Bordallo Jose LuisStorm Kevin Huntley
Solicitantes
Smithkline Beecham Laboratoires PharmaceutiquesSmithkline Beecham LabSmithkline Beecham S.A.
Clasificacion ipc
A61K 31/ 43 A IA61K 9/ 20 A IA61K 9/ 26 A IA61K 9/ 50 A I
Clasificacion cpc
424/469514/192514/210.09